[ad_1]
03.28.2021 03:00; Pavlina Trifonova
London and the EU enter a new vaccine war, accused of storing unused doses
The AstraZeneca and Oxford vaccine is 100% effective in preventing severe COVID-19 illness and hospital admission. 79% is the effect of the drug in the prevention of symptomatic diseases, said Mene Pangalos, executive vice president of AstraZeneca, responsible for biopharmaceutical research. The data comes from a long-awaited American study of more than 32,000 people in the United States, Chile and Peru, which paves the way for the drug’s approval in the United States.
80% is the effectiveness of the vaccine
in people over 65
These were about 20% of the participants in the new tests. There is no increased risk of blood clots after the first dose, said AstraZeneca’s executive vice president. New test data shows that the Oxford / AstraZeneca vaccine is just as effective for people of different races and age groups. Almost 60% of the volunteers had health problems known to increase the risk of developing severe COVID-19. Doses are given at 4 week intervals, but data shows that increasing this period further increases the effectiveness of the drug.
Approval from the US Federal Food and Drug Administration is expected in a few weeks, said Ruud Dober, AstraZeneca’s executive vice president, in charge of the company’s commercial department. “So far, a total of more than 70 countries on 6 continents have granted emergency or conditional approval for commercialization,” he said.
The figures come amid new tensions between Britain and the EU over the distribution of vaccines produced on its territory. It was announced that European leaders would on Thursday discuss a ban on the export of vaccines from AstraZeneca’s plant in the Netherlands to secure supplies from European countries. Therefore
Great Britain will not receive
20 million doses on which it is based,
vaccinate its entire adult population at the end of July. So far, it has managed to give a first injection to around 40% of its citizens, while in the EU those vaccinated are below 12%.
Brussels said 41 million doses of European plants had been exported to 33 countries in recent weeks, and 10 million to the island. Britain has responded to accusations of vaccination nationalism with reports that it has invested millions in the vaccine at Oxford and hired months before the EU did.
Furthermore, there is data that there are around 12 million doses of AstraZeneca in the EU that are not used due to abuse of confidence in the vaccine. For fear that it could cause clots, its placement was suspended for some time in dozens of countries, including Bulgaria.
British Prime Minister Boris Johnson has announced that he will try to find a compromise solution with his European counterparts. According to him, Britain should not be fooled that it will not feel the effect of the increasing cases of coronavirus in Europe, although on its territory they are falling drastically.
[ad_2]
